As company Schott has reached its 80th manufacturing anniversary it has committed to investing more in its pharmaceutical plant in Itupeva, Brazil.
The company plans to support the growing domestic pharmaceutical companies by supplying high-quality pharma packaging that is manufactured locally.
Located near São Paulo, the plant is home to state-of-the-art production of high-quality ampoules, vials, and cartridges.
The packing manufacturer has so far spent BRL 15 million on the facility and products manufactured in Itupeva are used by pharma companies to safely store and administer life-saving medications to patients.
Andreas Reisse, Executive Vice President of Schott’s Pharmaceutical Systems Business Unit, said: “We want to make sure that our South American customers are supplied in the best possible way.”
Schott believe that Brazil have great future prospects. Firstly, a study by IMS Health found by 2018 Brazil will most likely replace Germany as the fifth major pharma market in the world. Brazil is said to be the only country in the world that has a universal and free public health care system. Secondly, the average income is on the rise, and more and more Brazilians are joining private health plans. Finally, an ever-aging population demands more health care.
Jürgen Buhr, Director of Schott Pharmaceutical Systems in Brazil, says: “The pharmaceutical industry in Brazil can make significant progress based on this growth in health care expenditure and Schott will be a very supportive partner when it comes to realizing these growth objectives.”